For example, systemic administration of KOR antagonists in model species reliably reverses escalated drug and alcohol consumption resulting from chronic exposure [13–17], ameliorates depression-like phenotypes [18, 19], and can prevent the behavioral consequences of chronic stress [20–23]. Here, OPRK1 is linked to major depressive disorder.